The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis and uterine fibroids , as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. Experience leading projects effectively with multiple departments/stakeholders in a pharmaceutical company such as, but not limited to, multiple field teams, marketing, marketing operations, field operations, IT, commercial operations, and compliance/legal.